 |
|
Anticoagulation in Patients with End-Stage Renal Disease and Atrial Fibrillation: Confusion, Concerns and Consequences
Narender Goel, Deepika Jain, Danny B. Haddad, Divya Shanbhogue
J Stroke. 2020;22(3):306-316. Published online 2020 Sep 29 DOI: https://doi.org/10.5853/jos.2020.01886
|
|
Citations to this article as recorded by
 Antithrombotic therapy in diabetes: which, when, and for how long?
Ramzi A Ajjan, Noppadol Kietsiriroje, Lina Badimon, Gemma Vilahur, Diana A Gorog, Dominick J Angiolillo, David A Russell, Bianca Rocca, Robert F Storey
European Heart Journal.2021; 42(23): 2235. CrossRef Many Good Reasons to Switch from Vitamin K Antagonists to Non-Vitamin K Antagonists in Patients with Non-Valvular Atrial Fibrillation
Giovanni Luca Botto, Pietro Ameri, Raffaele De Caterina
Journal of Clinical Medicine.2021; 10(13): 2866. CrossRef Hemoperitoneum After Cardiopulmonary Resuscitation in Peritoneal Dialysis Patients: A Tale of Two Cases Narender Goel, Danny B Haddad, Deepika Jain
International Journal of Nephrology and Renovascular Disease.2020; Volume 13: 379. CrossRef
|